Biological peripheral correlates of anxiety

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Anxiety is associated with physiological and neuroendocrine changes, including elevated plasma cortisol and catecholamines.
• The specificity of these changes in anxiety disorders requires further investigation.
• Central noradrenergic system activity, measured in cerebrospinal fluid (CSF) or blood, correlates with anxiety symptoms.

Purpose of the Study:

• To explore the role of the noradrenergic system, specifically the locus coeruleus (LC), in anxiety.
• To review animal models and pharmacological evidence related to LC function and anxiety.
• To examine the potential of targeting LC activity for anxiety treatment.

Main Methods:

• Review of existing literature on anxiety correlates and the noradrenergic system.
• Examination of Redmond's (1979) model of anxiety based on LC function.
• Analysis of animal studies involving electrical and pharmacological manipulation of the LC.
• Evaluation of drug effects on LC activity and anxiety-related behaviors.

Main Results:

• Activation of the LC in animals increases norepinephrine (NE) turnover and fear behaviors.
• Inhibition of LC activity in animals decreases NE turnover and fear behaviors.
• Anxiolytic drugs in humans reduce LC firing in animals.
• Clonidine, an alpha-2 adrenergic agonist, inhibits LC activity and may have therapeutic effects in depression and anxiety.

Conclusions:

• The locus coeruleus (LC) is a key neuroanatomical structure implicated in anxiety.
• Modulating LC activity presents a potential therapeutic strategy for anxiety disorders.
• Further research into the noradrenergic system's role in anxiety is warranted.